Although children are likely to have a milder COVID-19 course compared with adults, MIS-C
as a postinfectious and life-threatening complication was reported in the pediatric age. After …

Although the underlying disease is associated with a severe course in adults and laboratory
abnormalities have been widely reported, there are not sufficient data on the clinical course …

The literature on neonates with SARS-CoV-2 is mainly concerned with perinatal cases, and
scanty data are available about environmentally infected neonates. To fill knowledge gaps …

Introduction It is not clear whether asthma, the most frequent chronic disease in childhood, is
a risk for severe SARS‐CoV‐2 infection in the pediatric population and how SARS‐CoV‐2 …

Background The aim of this study was to evaluate hematological parameters in children with
COVID-19 and determine the effects of inflammatory biomarkers on the assessment of …

The effects of biological disease-modifying antirheumatic drugs (bDMARDs) in the clinical
course of COVID-19 on children with underlying rheumatologic diseases have not been fully …

BackgroundThis meta-analysis provides a quantitative measure of the
otorhinolaryngological manifestations of coronavirus disease 2019 in children. MethodsA …

Background The aim was to evaluate the epidemiological, clinical, laboratory, and radiologic
data of children with SARS-CoV-2 positivity by polymerase chain reaction (PCR) together …

Aim We aimed to assess the impact of COVID‐19 on asthma exacerbations and to compare
the severity of symptoms of SARS‐CoV‐2 infection of asthmatic children with those of …

Understanding differences in terms of clinical phenotypes and outcomes of coronavirus
disease 2019 (COVID‐19) compared with influenza is vital to optimizing the management of …